AR017877A1 - Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo - Google Patents

Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo

Info

Publication number
AR017877A1
AR017877A1 ARP980106418A ARP980106418A AR017877A1 AR 017877 A1 AR017877 A1 AR 017877A1 AR P980106418 A ARP980106418 A AR P980106418A AR P980106418 A ARP980106418 A AR P980106418A AR 017877 A1 AR017877 A1 AR 017877A1
Authority
AR
Argentina
Prior art keywords
mastitis
type
mothers
treatment
xantofila
Prior art date
Application number
ARP980106418A
Other languages
English (en)
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Publication of AR017877A1 publication Critical patent/AR017877A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se describen un método para el tratamiento profiláctico de la mastitis en madres de mamíferos, inclusive madres humanas. El método comprende laadministracion a dichas madres de dosis profilácticamente efectivas de un medicamento humano o veterinarioque contiene por lo menos un tipo de xantofilas, talcomo la astaxantina. Preferentemente la astaxantina existe en una forma esterificada con ácidos grasos, por ejemplo, en la forma de una harina de algasproducida mediante el cultivo del algaHeamatoc occus sp. Además, se revela el uso de por lo menos un tipo de xantofinas, tal como la astaxantina, para lapreparacion de un medicamento humano o veterinario para el tratamiento profiláctico de la mastitis en madres de mamíferos, incluyendohumanas.
ARP980106418A 1997-12-16 1998-12-16 Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo AR017877A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Publications (1)

Publication Number Publication Date
AR017877A1 true AR017877A1 (es) 2001-10-24

Family

ID=20409414

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106418A AR017877A1 (es) 1997-12-16 1998-12-16 Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo

Country Status (12)

Country Link
US (1) US6335015B1 (es)
EP (1) EP1049460B1 (es)
JP (1) JP2002508318A (es)
AR (1) AR017877A1 (es)
AT (1) ATE239457T1 (es)
AU (1) AU743198B2 (es)
CA (1) CA2314170C (es)
DE (1) DE69814467D1 (es)
NO (1) NO327301B1 (es)
NZ (1) NZ504801A (es)
SE (1) SE511237C2 (es)
WO (1) WO1999030701A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7345091B2 (en) 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
EP1532108B1 (en) 2002-07-29 2016-06-29 Cardax Pharma, Inc. Astaxanthin esters for the inhibition and amelioration of disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
CA2564066A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2006034570A1 (en) 2004-09-28 2006-04-06 Chemaphor Inc. Compositions and methods for promoting weight gain and feed conversion
WO2006039685A2 (en) * 2004-10-01 2006-04-13 Hawaii Biotech, Inc. Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid derivatives
AU2008316225B2 (en) 2007-10-26 2014-06-19 Avivagen Inc. Compositions and methods for enhancing immune response
WO2010124392A1 (en) * 2009-04-30 2010-11-04 Chemaphor Inc. Methods, compositions, and kits for the treatment of inflammatory conditions
WO2010124391A1 (en) 2009-04-30 2010-11-04 Chemaphor Inc. Methods and compositions for improving the health of animals
CA3168140A1 (en) * 2020-02-18 2021-08-26 Avivagen Inc. Supplemented animal feeds for mammals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2619491B2 (ja) 1988-08-11 1997-06-11 サントリー株式会社 アスタキサンチン含有組成物
AU4715796A (en) 1995-02-03 1996-08-21 Basf Aktiengesellschaft Use of carotinoids for preparing medicaments for treating dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE506191C2 (sv) * 1996-03-27 1997-11-17 Astacarotene Ab Medel och sätt för att öka produktionen av/hos däggdjur

Also Published As

Publication number Publication date
NO20003042D0 (no) 2000-06-14
SE9704693L (sv) 1999-06-17
NO327301B1 (no) 2009-06-02
DE69814467D1 (de) 2003-06-12
NZ504801A (en) 2002-05-31
ATE239457T1 (de) 2003-05-15
CA2314170A1 (en) 1999-06-24
WO1999030701A1 (en) 1999-06-24
JP2002508318A (ja) 2002-03-19
US6335015B1 (en) 2002-01-01
SE511237C2 (sv) 1999-08-30
SE9704693D0 (sv) 1997-12-16
EP1049460A1 (en) 2000-11-08
AU1897299A (en) 1999-07-05
AU743198B2 (en) 2002-01-24
EP1049460B1 (en) 2003-05-07
NO20003042L (no) 2000-06-14
CA2314170C (en) 2008-01-29

Similar Documents

Publication Publication Date Title
AR017877A1 (es) Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
UY26330A1 (es) " método para mejorar la piel y el pelaje de mascotas".
ATE232393T1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung
DK1011653T3 (da) Anvendelse af xanthophyller i medikamenter til forbedring af varigheden af muskelfunktion eller behandling af muskelforstyrrelser eller -lidelser
DE69815677D1 (de) Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
ATE108334T1 (de) Immunotherapeutisches zubereitungen für die behandlung von aids.
AR032248A1 (es) Preparacion para mejorar la asimilacion de los alimentos
ATE274916T1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
DK165903C (da) Farmaceutisk praeparat mod acne
ZA202306644B (en) Application of chinese liquor in the preparation of medicines for improving intestinal barrier functions and gut microbiota
WO2020210712A3 (en) Ir700 nanocompositions for cardiac therapies and applications
SE9803541D0 (sv) Treatment of dyspepsia
SE9704590D0 (sv) Method of increasing the production and improving the quality of semen
PT651654E (pt) Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ES2145114T3 (es) Combinacion de atovacuona con proguanil para el tratamiento de infecciones protozoarias.
AR045070A1 (es) Preparados farmaceuticos topicos de acido ascorbico con efecto post-antimicotico
ES2112517T3 (es) Antibioticos ge 37468 a, b y c.
Saha et al. Mycobacterium chelonae infection complicating cosmetic facial surgery
ES2581180B1 (es) Uso de aloe oral para la mejora capilar
AU2001278375A1 (en) Composition for pharmaceutical and cosmetic products
Dharmapalan et al. Nature Itself Is The Best Medicine–Herbal Local Drug Delivery In Periodontitis
CN111150779A (zh) 一种治疗口腔溃疡的中药
CN109125402A (zh) 一种治疗皮肤烫伤软膏剂

Legal Events

Date Code Title Description
FB Suspension of granting procedure